NSAIDs: ENdocannabinoid stimulating anti-inflammatory drugs?

Trends in Pharmacological Sciences

Volumn 33, Issue 9, 2012, Pages 468-473

  Fowler, Christopher J ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; ARACHIDONIC ACID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CELECOXIB; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIPYRONE; DRONABINOL; ENDOCANNABINOID; FLURBIPROFEN; G PROTEIN COUPLED RECEPTOR; IBUPROFEN; INDOMETACIN; KETOROLAC; L745337; MEFENAMIC ACID; MORPHINE; NABILONE; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROSTAGLANDIN; RIMONABANT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALGESIC ACTIVITY; CONCENTRATION (PARAMETERS); DISEASE MODEL; DRUG DEVELOPMENT; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; ENDOCANNABINOID SYSTEM; ENZYME INHIBITION; ENZYME METABOLISM; GASTROINTESTINAL TOXICITY; HUMAN; INFLAMMATORY PAIN; NERVE LIGATION; NERVOUS SYSTEM; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN; PAIN THRESHOLD; PLACEBO EFFECT; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SPINAL NERVE;

EID: 84865277383     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2012.05.003     Document Type: Short Survey

References (70)

1. C.A. Rouzer, and L.J. Marnett Cyclooxygenases: structural and functional insights J. Lipid Res. 50 Suppl. 2009 S29 S34
2. J. Vane Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nat. New Biol. 231 1971 232 235
3. J.M. Ritter Precaution, cyclooxygenation, and cardiovascular risk Trends Pharmacol. Sci. 30 2009 503 508
4. S. Trelle Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis BMJ 342 2011 c7086
5. J.L. Wallace NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies Br. J. Pharmacol. 165 2012 67 74
6. J.L. Wallace Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis Trends Pharmacol. Sci. 30 2009 112 117
7. G.E. Rovati Dual COXIB/TP antagonists: a possible new twist in NSAID pharmacology and cardiovascular risk Trends Pharmacol. Sci. 31 2010 102 107
8. 2 Pharmacol. Rev. 62 2010 588 631
9. G. Labar, and C. Michaux Fatty acid amide hydrolase: from characterization to therapeutics Chem. Biodivers. 4 2007 1882 1902 (Pubitemid 47377207)
10. N. Ueda Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol Biofactors 37 2011 1 7
11. B.F. Cravatt Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase Proc. Natl. Acad. Sci. U.S.A. 98 2001 9371 9376 (Pubitemid 32743923)
12. S. Kathuria Modulation of anxiety through blockade of anandamide hydrolysis Nat. Med. 9 2003 76 81 (Pubitemid 36098263)
13. J.Z. Long Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects Nat. Chem. Biol. 5 2009 37 44
14. K.R. Kozak, and L.J. Marnett Oxidative metabolism of endocannabinoids Prostaglandins Leukot. Essent. Fatty Acids 66 2002 211 220 (Pubitemid 34743596)
15. N.T. Snider Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome p450 monooxygenases: physiological and pharmacological implications Pharmacol. Rev. 62 2010 136 154
16. E.J. Rahn, and A.G. Hohmann Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside Neurotherapeutics 6 2009 713 737
17. B.P. Roques Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain Nat. Rev. Drug Discov. 11 2012 292 310
18. C.J. Fowler Monoacylglycerol lipase - a target for drug development? Br. J. Pharmacol. 166 2012 1568 1585
19. M.E. Lynch, and F. Campbell Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials Br. J. Clin. Pharmacol. 72 2011 735 744
20. H. Gühring A role for endocannabinoids in indomethacin-induced spinal antinociception Eur. J. Pharmacol. 454 2002 153 163 (Pubitemid 35287474)
21. A. Telleria-Diaz Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: involvement of prostaglandins and endocannabinoids Pain 148 2010 26 35
22. M. Ates Intrathecally applied flurbiprofen produces an endocannabinoid-dependent antinociception in the rat formalin test Eur. J. Neurosci. 17 2003 597 604 (Pubitemid 36255896)
23. L. Staniaszek Effects of COX-2 inhibition on spinal nociception: the role of endocannabinoids Br. J. Pharmacol. 160 2010 669 676
24. R.M. Rezende Endogenous opioid and cannabinoid mechanisms are involved in the analgesic effects of celecoxib in the central nervous system Pharmacology 89 2012 127 136
25. P. Bishay R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids PLoS ONE 5 2010 e10628
26. F. Benedetti Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors Nat. Med. 17 2011 1228 1230
27. S. Petrosino Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats Neuropharmacology 52 2007 415 422 (Pubitemid 46127787)
28. L. Guasti Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain Mol. Pain 5 2009 35
29. G. Schelling Effects of general anesthesia on anandamide blood levels in humans Anesthesiology 104 2006 273 277
30. I. Khasabova A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain J. Neurosci. 28 2008 11141 11152
31. I. Lever Localization of the endocannabinoid-degrading enzyme fatty acid amide hydrolase in rat dorsal root ganglion cells and its regulation after peripheral nerve injury J. Neurosci. 29 2009 3766 3780
32. M. Bracey Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling Science 298 2002 1793 1796 (Pubitemid 35404124)
33. B. Paria The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period Mol. Reprod. Dev. 45 1996 183 192 (Pubitemid 26382492)
34. C.J. Fowler Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship J. Pharmacol. Exp. Ther. 283 1997 729 734 (Pubitemid 27514633)
35. C.J. Fowler Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen Arch. Biochem. Biophys. 362 1999 191 196 (Pubitemid 29394346)
36. C.J. Fowler Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner J. Enzyme Inhib. Med. Chem. 18 2003 55 58 (Pubitemid 36221714)
37. C. Häbler Über den K- und Ca-gehalt von eiter und exsudaten und seine beziehungen zum entzündungsschmerz Klin. Wochenschr. 8 1929 1569 1572 (in German)
38. S. Holt, and C.J. Fowler Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra- but not intracellular pH Naunyn Schmiedebergs Arch. Pharmacol. 367 2003 237 244 (Pubitemid 36408005)
39. J. Guindon Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain Pain 121 2006 85 93 (Pubitemid 43261635)
40. S. Holt Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors Br. J. Pharmacol. 146 2005 467 476 (Pubitemid 41486689)
41. J.J. Prusakiewicz Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid Biochemistry 48 2009 7353 7355
42. K.C. Duggan (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2 Nat. Chem. Biol. 7 2011 803 809
43. C.J. Fowler Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide J. Enzyme Inhib. Med. Chem. 2012 10.3109/14756366.2011.643304
44. K.R. Kozak Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid 2-arachidonylglycerol J. Biol. Chem. 276 2001 30072 30077
45. K.R. Kozak Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide Biochemistry 42 2003 9041 9049 (Pubitemid 36935412)
46. A.J. Vecchio, and M.G. Malkowski The structural basis of endocannabinoid oxygenation by cyclooxygenase-2 J. Biol. Chem. 286 2011 20736 20745
47. 1 cannabinoid receptor trafficking by the adaptor protein AP-3 FASEB J. 22 2008 2311 2322 (Pubitemid 351948649)
48. 1) receptors are activated by anandamide J. Biol. Chem. 286 2011 29166 29174
49. M. Beltramo CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms Eur. J. Neurosci. 23 2006 1530 1538
50. L. Jean-Gilles Interaction between cytokines, cannabinoids and the nervous system Immunobiology 215 2010 606 610
51. A. Singh Tahim Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons Neuroscience 136 2005 539 548 (Pubitemid 41607902)
52. G. Horvath The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level Pain 134 2008 277 284
53. S.-J. Hu Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFκB activity Br. J. Pharmacol. 153 2008 1538 1549
54. E. Högestätt Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system J. Biol. Chem. 280 2005 31405 31412 (Pubitemid 41291881)
55. M. Beltramo Functional role of high-affinity anandamide transport, as revealed by selective inhibition Science 277 1997 1094 1097 (Pubitemid 27371630)
56. C. Mallet Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia Pain 139 2008 190 200
57. 2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice Eur. J. Pharmacol. 546 2006 60 68 (Pubitemid 44348895)
58. 1 in brain is involved in acetaminophen-induced antinociception PLoS ONE 5 2010 e12748
59. M. Soukupová Effects of URB597, an inhibitor of fatty acid amide hydrolase (FAAH), on analgesic activity of paracetamol Neuroendocrinol. Lett. 31 2010 507 511
60. T. Rogosch Novel bioactive metabolites of dipyrone (metamizol) Bioorg. Med. Chem. 20 2012 101 107
61. J. Lötsch Effects of flurbiprofen enantiomers on pain-related chemo-somatosensory evoked potentials in human subjects Br. J. Clin. Pharmacol. 40 1995 339 346
62. N.M. Davies Effect of the enantiomers of flurbiprofen, ibuprofen, and ketoprofen on intestinal permeability J. Pharm. Sci. 85 1996 1170 1173 (Pubitemid 26372883)
63. P. Naidu Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception J. Pharmacol. Exp. Ther. 329 2009 48 56
64. O. Sasso Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions Pharmacol. Res. 65 2012 553 563
65. S.G. Kinsey Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice J. Pharmacol. Exp. Ther. 338 2011 795 802
66. S. Holt Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin Eur. J. Pharmacol. 565 2007 26 36 (Pubitemid 46782775)
67. F. De Wael Chemistry around imidazopyrazine and ibuprofen: discovery of novel fatty acid amide hydrolase (FAAH) inhibitors Eur. J. Med. Chem. 45 2010 3564 3574
68. 2 receptor, CRTH2 Br. J. Pharmacol. 137 2002 1163 1172 (Pubitemid 36071733)
69. G. Reid The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs Proc. Natl. Acad. Sci. U.S.A. 100 2003 9244 9249 (Pubitemid 37033914)
70. J. Lehmann Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs J. Biol. Chem. 272 1997 3406 3410